SARS-CoV-2 M <sup>pro</sup> inhibitors with antiviral activity in a transgenic mouse modelJingxin Qiao, Shengyong Yang, Kai Wang et al.|Science|2021Cited by 449
An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including OmicronBaoxue Quan, Shengyong Yang, Huiping Shuai et al.|Nature Microbiology|2022Cited by 101
A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variantsChong Huang, Shengyong Yang, Huiping Shuai et al.|Signal Transduction and Targeted Therapy|2023Cited by 82
An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivoHuiping Shuai, Hin Chu, Jingxin Qiao et al.|Nature Communications|2025Cited by 8
An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivoHin Chu, Shengyong Yang, Huiping Shuai et al.|Research Square|2024Cited by 1